Akay, Fatih ErkanKoçyiğit, BelizŞişman, Fevzi OktayAyrık, Mert YücelSavaşır, İpekCengiz, ElifDemirci, Ufuk2021-11-202021-11-2020212148-47242548-0030https://dergipark.org.tr/tr/pub/tmsj/issue/60525/889334https://dergipark.org.tr/tr/download/article-file/1611273https://hdl.handle.net/20.500.14551/6253Aims: To establish a dataset including demographic features, disease characteristics, and survival rate of follicular lymphoma patients in Trakya Universi- ty School of Medicine and contribute to the database of follicular lymphoma in Turkey. Methods: In this retrospective cross-sectional study, we analyzed data constituting of follicular lymphoma patients over 18 years of age followed during the years of 2015-2020 in Trakya University Division of Hematology. Results: Out of 43 patients, 22 (51.2%) were female and 21 (48.8%) were male. The mean age was 56.56 (standard deviation 13.24) years. There were 5 (11.6%) pa- tients with B symptoms, presence of bone marrow involvement was seen in 17 (39.5%) patients, lastly, there were 18 (41.9%) patients with splenomegaly. Twen- ty-one (48.8%) patients received rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate, and prednisone, making it the most common treatment protocol administered in our study. Conclusion: Follicular lymphoma patients usually end up getting diagnosed at an advanced stage of the disease, presenting with incidentally noticed painless lymphadenopathy. Additionally, based on evidence in the literature, a clear gap in the successful diagnosis of follic- ular lymphoma patients can be observed between developed and developing countries. To overcome this hurdle, enhanced cooperation with hematopathology may lead to an increased awareness enabling physicians to make a more accurate diagnosis. Nonetheless, further studies are still needed to fully apprehend the epidemiology of follicular lymphoma patients in Turkey.eninfo:eu-repo/semantics/openAccessFollicular lymphomaretrospective studynon-Hodgkin’s lymphomasRetrospective Analysis of Follicular Lymphoma Patients in Trakya University School of Medicine: a Single Center ExperienceArticle812831889334